Medical News

RSS

Dems expect 9/11 'first responders' bill to pass today

CongressDaily: "At the urging of what one aide called 12 'pushy' New York lawmakers, House Democratic leaders plan to bring to the floor today legislation that would extend healthcare aid to 9/11 first responders. ... The $7.4 billion measure would provide health monitoring and treatment benefits to first responders and survivors of the Sept. 11, 2001, terrorist attacks.

29 Sep 2010

Political cartoon: 'Witchcraft?'

Kaiser Health News provides this fresh take on health policy developments with "Witchcraft?" by Nate Beeler.

29 Sep 2010

Triple-S Management board authorizes $30M share repurchase program

Triple-S Management Corporation today announced that its Board of Directors has authorized a $30 million share repurchase program, which will commence immediately. It will be conducted, using available cash, through open-market purchases and privately-negotiated transactions of Class B shares only, in accordance with Rules 10b-18 and 10b5-1 under the Securities Exchange Act of 1934, as amended.

29 Sep 2010

Apricus Biosciences prices securities offering

Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that it has entered into agreements with selected investors to sell up to 1,728,882 Units at a price per Unit of $5.40, for aggregate gross proceeds of approximately $9.3 million.

29 Sep 2010

Crocker Ventures announces acquisition of TMJ Implants

Crocker Ventures today announced that it has acquired TMJ Implants of Golden, Colo., the leading manufacturer of implants for the treatment of temporomandibular joint (TMJ) disorder.

29 Sep 2010

Medivation and Astellas commence MDV3100 second Phase 3 clinical trial in advanced prostate cancer

Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.

29 Sep 2010

Keryx commences Zerenex Phase 3 study for hyperphosphatemia in patients with ESRD on dialysis

Keryx Biopharmaceuticals, Inc. announced today the initiation of the long-term Phase 3 study of Zerenex™ (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis.

29 Sep 2010

NeurAxon closes convertible debenture financing

NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced that it has closed a convertible debenture financing in which the convertible debentures are convertible under specified circumstances into existing class B preferred shares for a total of approximately $14 million.

29 Sep 2010

Senesco fiscal 2010 revenue decreases to $140,000

Senesco Technologies, Inc. reported financial results for the 12 months ended June 30, 2010 ("Fiscal 2010").

29 Sep 2010

Kaiser Permanente donates Convergent Medical Terminology for open access

Kaiser Permanente is donating its Convergent Medical Terminology (CMT) for open access to help facilitate the nation's transition from paper-based medical records to Electronic Health Records (EHR). CMT was designed by clinicians to facilitate the use of EHRs by clinicians and patients. Kaiser Permanente has the world's largest private sector electronic health record.

29 Sep 2010

NINDS establishes new sites as part of Morris K. Udall Centers of Excellence in Parkinson's Disease Research

The National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health, has established two new sites as part of the Morris K. Udall Centers of Excellence in Parkinson's Disease Research. The NINDS grants will provide a five-year investment totaling more than $16 million for Emory University in Atlanta and the Feinstein Institute for Medical Research in Manhasset, N.Y.

29 Sep 2010

NIAID study utilizes Biojector B2000 system to explore syringe, needle benefits

Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, today announced that its unique Needle-Free Injection Therapy (NFIT) system, the Biojector 2000, is being utilized in a study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) which is part of the U.S. National Institutes of Health (NIH).

29 Sep 2010

Rigel earns $25M milestone payment from Astrazeneca for clinical development of fostamatinib

Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.

29 Sep 2010

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc., today announced the latest results from the IN.PACT drug-eluting balloon (DEB) clinical program presented last week at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference.

29 Sep 2010

Study links noise and stochastic resonance to higher cognitive functions and attention

Playing white noise in class can help inattentive children learn. Researchers writing in BioMed Central's open access journal Behavioral and Brain Functions tested the effect of the meaningless random noise on a group of 51 schoolchildren, finding that although it hindered the ability of those who normally pay attention, it improved the memory of those that had difficulties in paying attention.

29 Sep 2010

Neurons that control sexual behavior mapped

How the bundles of neurons in the brain controls behaviour remains an ongoing mystery. Researchers from the Institute of Molecular Pathology (IMP), in Vienna, Austria, and the Laboratory of Molecular Biology (LMB/MRC), Cambridge, United Kingdom, have mapped neurons of the fruit fly, Drosophila, that controls sexual behavior. "We literally untangled the mess of wires in the fly brain and laid the ground plans for investigating a complex behavior in a simple organism," says Jai Yu, whose doctoral work is published in Current Biology.

29 Sep 2010

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

GeneGo, Inc., the leading systems biology tools company and Omicsoft Corporation, the leader in the OMIC repository and analysis field, announced today integration of Omicsoft's Next Generation Sequencing tools with GeneGo's MetaCore data mining suite.

29 Sep 2010

Centric Health acquires two pharmacies on Southlake Regional Health Centre campus in Ontario

Centric Health Corporation, Canada's leading diversified healthcare company, today announced that it has acquired, in partnership, two pharmacies located on the Southlake Regional Health Centre campus in Newmarket, Ontario.

29 Sep 2010

AccessClosure enters agreement with Benrikal Services for Bengal Radial Compression Band distribution

AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Benrikal Services to distribute the Bengal Radial Compression Band in the United States.

29 Sep 2010

TeleHealth Services extends partnership with SVHC to enhance patient education initiatives

TeleHealth Services, the nation's leading provider of healthcare-grade televisions and interactive patient education solutions, today announced an extension of a seven year partnership with St. Vincent's HealthCare (SVHC) to further enhance the hospital's patient education initiatives. The health system will utilize TeleHealth's technology in St. Vincent's Medical Center and new addition, St. Luke's Hospital.

29 Sep 2010

Medical News

Dems expect 9/11 'first responders' bill to pass today

Political cartoon: 'Witchcraft?'

Triple-S Management board authorizes $30M share repurchase program

Apricus Biosciences prices securities offering

Crocker Ventures announces acquisition of TMJ Implants

Medivation and Astellas commence MDV3100 second Phase 3 clinical trial in advanced prostate cancer

Keryx commences Zerenex Phase 3 study for hyperphosphatemia in patients with ESRD on dialysis

NeurAxon closes convertible debenture financing

Senesco fiscal 2010 revenue decreases to $140,000

Kaiser Permanente donates Convergent Medical Terminology for open access

NINDS establishes new sites as part of Morris K. Udall Centers of Excellence in Parkinson's Disease Research

NIAID study utilizes Biojector B2000 system to explore syringe, needle benefits

Rigel earns $25M milestone payment from Astrazeneca for clinical development of fostamatinib

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

Study links noise and stochastic resonance to higher cognitive functions and attention

Neurons that control sexual behavior mapped

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

Centric Health acquires two pharmacies on Southlake Regional Health Centre campus in Ontario

AccessClosure enters agreement with Benrikal Services for Bengal Radial Compression Band distribution

TeleHealth Services extends partnership with SVHC to enhance patient education initiatives

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News